In hepatocellular carcinoma, overexpression of CD24 leads to increased production of PP2A protein, induces inactivation of the AKT/mTOR pathway, elevates autophagy levels, and results in resistance to sorafenib [86,87] (Fig. 3C). Here, CD24 is linked to hepatocellular carcinoma.